Are you Dr. Champsi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 45 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
1200 El Camino Real
South San Francisco, CA 94080Phone+1 650-742-2000
Summary
- Dr. Jamila Champsi, MD is an infectious disease specialist in South San Francisco, California. She is currently licensed to practice medicine in California and Arizona. She is affiliated with Kaiser Permanente South San Francisco Medical Center and St. Mary's Medical Center.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1991 - 1994
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1989 - 1991
- California Pacific Medical CenterInternship, Internal Medicine, 1988 - 1989
- University of Arizona College of MedicineClass of 1988
Certifications & Licensure
- AZ State Medical License 1992 - 2026
- CA State Medical License 1990 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Publications & Presentations
PubMed
- 1 citationsAntibiotic duration and route for treatment of adults with uncomplicated streptococcal bloodstream infections: a retrospective study in a large healthcare system.Dana S Clutter, Zahra Samiezade-Yazd, Jamila H Champsi, Jeffrey Schapiro, Michael J Silverberg
Antimicrobial Agents and Chemotherapy. 2024-08-07 - Impact of COVID-19 on myalgic encephalomyelitis/chronic fatigue syndrome-like illness prevalence: A cross-sectional survey.Mariah S Wood, Nicole Halmer, Jeanne Bertolli, Laura B Amsden, Joshua R Nugent
Plos One. 2024-01-01 - 10 citationsCancer in People with and without Hepatitis C Virus Infection: Comparison of Risk Before and After Introduction of Direct-Acting Antivirals.Jennifer O Lam, Leo B. Hurley, Jennifer B. Lai, Varun Saxena, Suk I. Seo
Cancer Epidemiology, Biomarkers & Prevention. 2021-09-28
Press Mentions
- Health Officials Are Advising the Public to Get Vaccinations as Respiratory Illnesses SpreadDecember 4th, 2023